The EGF secreted by the TAMs activates the EGFR/ STAT3/SOX‐2 paracrine pathway in the breast cancer, resulting in increased SOX‐2 expression, which in turn enhances the CSC phenotype in the tumor cells.38 This evidence concerns the gene EGF and breast cancer.